期刊文献+

制备高空隙率口腔崩解片的新方法 被引量:1

New method of preparing high-porosity rapidly saliva soluble disaggregated tablets using mannitol and ammonium bicarbonate
下载PDF
导出
摘要 目的:研究制备口腔崩解片的新方法。方法:将含有碳酸氢铵的片剂在干燥箱中加热至80℃,保温一段时间,碳酸氢铵全部分解成氨、水和二氧化碳从片剂中逸出,得高空隙片剂。考察碳酸氢铵用量、空隙率、硬度、含药量和硬脂酸镁与崩解时限的关系;考察加热温度和加热时间对碳酸氢铵残留量的影响。结果:碳酸氢铵用量、空隙率与崩解时限成反比;硬度、含药量和硬脂酸镁用量与崩解时限成正比;温度升高,加热时间延长,碳酸氢铵残留量减少。每片碳酸氢铵用量定为0.15g,硬脂酸镁用量为0.5%~1.5%,硬度为9kg,在80℃加热75min。结论:本方法简便易行,质量稳定可控,但碳酸氢铵残留量较高,有待进一步完善。 OBJECTIVE To research a new method of preparing high-porosity saliva soluble disaggregated tablets. METHODS The high-porosity saliva soluble disaggregated tablets of ammonium bicarbonate could be prepared by direct compression and heating at 80℃ ,ammonia water and carbon dioxide were liberated from the tablet. Furthermore, study the effects of different factors on disingtegrating time limit including the quantiry of ammonium bicarbonate, porosity, hardness, content of main ingredient and magnesium stearate,and study the relationship between ammonium bicarbonate remain quantity and heating tempreture and time. RESULIS The disintegrating time limit was proportional to porosity and content of ammonium bicarbonate, but was inversely proportional to hardness, contene of main ingredient and magnesium stearate. Forthermore, residual content of ammonium bicarbonate decreased along with temperature increasing and heating time extension. The tablets were prepared asfollowed: the content of ammonium bicarbonate was 0. 15 g, and the content range of magnesium stearate was 0. 5%-1.5% ; hardness was 9 kg,and heating 75 min at 80 ℃. CONCLUSION The method is feasible,further study is needed to eliminate residud ammonium bicarbonate.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2007年第9期1238-1240,共3页 Chinese Journal of Hospital Pharmacy
关键词 甘露醇 碳酸氢铵 口腔崩解片 空隙率 mannitol ammonium bicarbonate saliva soluble disaggregated tablets high-porosity rapidly
  • 相关文献

参考文献3

  • 1Koizumi K,Yamada M,Kikuta J.New method of preparing high porosity rapidly saliva soluble compressrd tablets using mannitol with camphor,a subliming material[J].Int J Pharm,1997,152(1):127-131.
  • 2陈岚,武新安,张国荣,魏爱红.口腔速崩片的研制与评价[J].中国医院药学杂志,2002,22(9):515-518. 被引量:45
  • 3中国药典.二部[S].2005.附录:29.

二级参考文献2

共引文献141

同被引文献9

  • 1张惠芹,袁秀红,覃惠英.老年人尿失禁易患因素及处理现状[J].现代临床护理,2006,5(5):83-85. 被引量:9
  • 2TOSHIHIRO I, YOSHINOBU A. Orally rapidly disintegra- ting tablet comprising imidafenacin [ P ]. USA : US2011/ 0002988 A1. Jan. 6,2011.
  • 3FU Y R, YANG S C, ]EONG S H. Orally fast disintegrating tablets : developments, technologies, taste-masking and clinical studies [ J ]. Crit Rev Ther Drug Carrier Systems, 2004, 21 (6) :433-475.
  • 4GOEL H, VORA N, RANA V. A novel approach to op- timize and formulate fast disintegrating tablets for nausea and vomiting [ J ]. AAPS Pharm Sci Tech, 2008,9 ( 3 ) : 774-781.
  • 5ABED K K, HUSSEIN A A, GHAREEB M M, et al. For- mulation and optimization of orodispersible tablets of diazepam [ J ]. AAPS Pharm Sci Tech, 2010,11 ( 1 ) : 356- 361.
  • 6BHOYAR P, BIYANI D, UMEKAR M. Formulation and characterization of patient-friendly dosage form of ondansetron [ J ]. J Young Pharm, 2010, 2 (3) : 240-246.
  • 7JUNG H A, AUGSBURGER L L. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet[ J]. Drug Dev Ind Pharm, 2012, 38 (7) :825-836.
  • 8RAWAS-QALAJ! M M, SIMONS F E, SIMONS K J. Fast- disintegrating sublingual epinephrine tablets:effect of tablet dimensions on tablet characteristics [ J 1. Drug Dev Ind Pharm, 2007,33 ( 5 ) : 523-530.
  • 9郭辉,张玉泉.膀胱过度活动症新药——咪达那新[J].齐鲁药事,2008,27(5):317-318. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部